Literature DB >> 20572151

QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance.

Saman Nazarian1, David A Bluemke, Kathryn R Wagner, Menekhem M Zviman, Evrim Turkbey, Brian S Caffo, Monda Shehata, David Edwards, Barbara Butcher, Hugh Calkins, Ronald D Berger, Henry R Halperin, Gordon F Tomaselli.   

Abstract

Current noninvasive surrogates of cardiac involvement in myotonic muscular dystrophy have low positive predictive value for sudden death. We hypothesized that the cardiac MR signal-to-noise ratio variance (SNRV) is a surrogate of the spatial heterogeneity of myocardial fibrosis and correlates with electrocardiography changes in myotonic muscular dystrophy. The SNRV for contrast enhanced cardiac MR images was calculated over the entire left ventricle in 43 patients with myotonic muscular dystrophy. All patients underwent standard electrocardiography, and a subset of 23 patients underwent signal averaged electrocardiography. After correcting for body mass index, age, and ejection fraction, SNRV was predictive of QRS duration on standard electrocardiography (1.35-msec increased QRS duration/unit increase in SNRV, P < 0.001). SNRV was also predictive of the low-amplitude late-potential duration (1.49-msec increased low-amplitude late-potential duration/unit increase in SNRV, P < 0.001). Ten-fold cross-validation yielded an area under the receiver operating characteristic curve of 0.87 for the predictive value of SNRV for QRS duration greater than 120 msec. The SNRV of the left ventricle is associated with QRS prolongation, likely due to late depolarization of tissue within islands of patchy fibrosis. The association of SNRV with future clinical events warrants further study. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572151      PMCID: PMC3034129          DOI: 10.1002/mrm.22417

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  33 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  The natural history of cardiac involvement in myotonic dystrophy: an eight-year follow-up in 17 patients.

Authors:  P Melacini; G Buja; G Fasoli; C Angelini; M Armani; R Scognamiglio; S Dalla Volta
Journal:  Clin Cardiol       Date:  1988-04       Impact factor: 2.882

3.  Ethnic distribution of myotonic dystrophy gene.

Authors:  T Ashizawa; H F Epstein
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

4.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

5.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

6.  Relation between myocardial histological changes and ventricular tachycardia in cardiomyopathy: a study by 24-hour ECG-monitoring and endomyocardial biopsy.

Authors:  I Segawa; T Suzuki; M Kato; A Tashiro; R Satodate
Journal:  Heart Vessels Suppl       Date:  1990

Review 7.  Cardiovascular manifestations of myotonic dystrophy-1.

Authors:  Ali A Sovari; C Kenneth Bodine; Farhad Farokhi
Journal:  Cardiol Rev       Date:  2007 Jul-Aug       Impact factor: 2.644

8.  Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy.

Authors:  M Sabovic; I Medica; N Logar; E Mandić; J Zidar; B Peterlin
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  6 in total

1.  The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.

Authors:  Auinash Kalsotra; Ravi K Singh; Priyatansh Gurha; Amanda J Ward; Chad J Creighton; Thomas A Cooper
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

2.  TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2.

Authors:  Francesca Bosè; Laura Valentina Renna; Barbara Fossati; Giovanni Arpa; Valentina Labate; Valentina Milani; Annalisa Botta; Emanuele Micaglio; Giovanni Meola; Rosanna Cardani
Journal:  Front Neurol       Date:  2019-09-27       Impact factor: 4.003

3.  Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy.

Authors:  Ashish N Rao; Hannah M Campbell; Xiangnan Guan; Tarah A Word; Xander Ht Wehrens; Zheng Xia; Thomas A Cooper
Journal:  JCI Insight       Date:  2021-03-08

4.  Deletion of Sphingosine 1-Phosphate receptor 1 in cardiomyocytes during development leads to abnormal ventricular conduction and fibrosis.

Authors:  Ryan Jorgensen; Meghna Katta; Jayne Wolfe; Desiree F Leach; Bianca Lavelle; Jerold Chun; Lisa D Wilsbacher
Journal:  Physiol Rep       Date:  2021-10

Review 5.  Cardiac Pathology in Myotonic Dystrophy Type 1.

Authors:  Mani S Mahadevan; Ramesh S Yadava; Mahua Mandal
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

6.  Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.

Authors:  Helle Petri; Kiril Aleksov Ahtarovski; Niels Vejlstrup; John Vissing; Nanna Witting; Lars Køber; Henning Bundgaard
Journal:  J Cardiovasc Magn Reson       Date:  2014-08-01       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.